Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anderson, A D G
Right arrow Articles by MacFie, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anderson, A D G
Right arrow Articles by MacFie, J
Topic Collections
Right arrowRelevant Article
Gut 2004;53:241-245
© 2004 by BMJ Publishing Group Ltd & British Society of Gastroenterology


INTESTINE MICROBIOLOGY

Randomised clinical trial of synbiotic therapy in elective surgical patients

A D G Anderson, C E McNaught, P K Jain, J MacFie

Combined Gastroenterology Research Group, Scarborough Hospital, Woodlands Drive, Scarborough, UK

Correspondence to:
Correspondence to:
Mr J MacFie
Scarborough Hospital, Woodlands Drive, Scarborough, YO12 6QL, UK; Johnmacfie{at}aol.com


ABSTRACT
Background: It is possible to manipulate the composition of the gastrointestinal microflora by administration of pre- and probiotics. This may help to preserve gut barrier function and reduce the incidence of septic morbidity.

Aims: To assess the effects of a combination of pre- and probiotics (synbiotic) on bacterial translocation, gastric colonisation, systemic inflammation, and septic morbidity in elective surgical patients.

Patients: Patients were enrolled two weeks prior to elective abdominal surgery. Seventy two patients were randomised to the synbiotic group and 65 to the placebo group. Patients were well matched regarding age and sex distribution, diagnoses, and POSSUM scores.

Methods: Patients in the synbiotic group received a two week preoperative course of Lactobacillus acidophilus La5, Bifidobacterium lactis Bb-12, Streptococcus thermophilus, and Lactobacillus bulgaricus, together with the prebiotic oligofructose. Patients in the placebo group received placebo capsules and sucrose powder. At surgery, a nasogastric aspirate, mesenteric lymph node, and scrapings of the terminal ileum were harvested for microbiological analysis. Serum was collected preoperatively and on postoperative days 1 and 7 for measurement of C reactive protein, interleukin 6, and antiendotoxin antibodies. Septic morbidity and mortality were recorded.

Results: There were no significant differences between the synbiotic and control groups in bacterial translocation (12.1% v 10.7%; p = 0.808, {chi}2), gastric colonisation (41% v 44%; p = 0.719), systemic inflammation, or septic complications (32% v 31%; p = 0.882).

Conclusions: In this study, synbiotics had no measurable effect on gut barrier function in elective surgical patients. Further studies investigating the place of pre- and probiotics in clinical practice are required.


Keywords: prebiotics; probiotics; synbiotics; bacterial translocation

Abbreviations: CRP, C reactive protein; IL-6, interleukin 6; IgM EndoCAb, antiendotoxin core antibody; POSSUM score, physiological and operative severity scores for enumeration of morbidity; IQR, interquartile range


Relevant Article

Digest
Robin Spiller
Gut 2004 53: 159. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Nutr.Home page
F. Guarner
Studies with Inulin-Type Fructans on Intestinal Infections, Permeability, and Inflammation
J. Nutr., November 1, 2007; 137(11): 2568S - 2571S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. Isakow, L. E. Morrow, and M. H. Kollef
Probiotics for Preventing and Treating Nosocomial Infections: Review of Current Evidence and Recommendations
Chest, July 1, 2007; 132(1): 286 - 294.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Alberda, L. Gramlich, J. Meddings, C. Field, L. McCargar, D. Kutsogiannis, R. Fedorak, and K. Madsen
Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial
Am. J. Clinical Nutrition, March 1, 2007; 85(3): 816 - 823.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. D. Luyer, W. A. Buurman, M. Hadfoune, G. Speelmans, J. Knol, J. A. Jacobs, C. H. C. Dejong, A. J. M. Vriesema, and J. W. M. Greve
Strain-Specific Effects of Probiotics on Gut Barrier Integrity following Hemorrhagic Shock
Infect. Immun., June 1, 2005; 73(6): 3686 - 3692.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
S. Bengmark and R. Martindale
Prebiotics and Synbiotics in Clinical Medicine
Nutr Clin Pract, April 1, 2005; 20(2): 244 - 261.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Society of Gastroenterology